Gregory Wells, MD
Dermatology · Meridian, IDNPI 1871609370
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,545 of the $3,389 with a category attached, or 75.1%. Merck accounts for 75.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $1,003 and has fallen 81.0% since, to $191 in 2025.
Across 50 payments — averaging $67.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3K
- AbbVie$419
- Novartis$148
- Johnson & Johnson$110
- Amgen$32
- Regeneron Healthcare Solutions, Inc.$31
- plus $105 from 5 others
What the payments were for
- Consulting fees$2,54575%
- Food & beverage$74422%
- Education$1003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 6 | $2,545 |
| AbbVie | 22 | $419 |
| Novartis | 10 | $148 |
| Johnson & Johnson | 2 | $110 |
| Amgen | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Galderma Laboratories, L.p. | 2 | $28 |
| Pfizer | 2 | $27 |
| Incyte Corporation | 1 | $22 |
| Sanofi | 1 | $16 |
| Sun Pharmaceutical Industries Inc. | 1 | $11 |
How this compares
$3,389 in reported general payments places this provider in the 65th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $91,667 |
| Clobetasol Propionate | 174 | $9,388 |
| Mycophenolate Mofetil | 27 | $7,178 |
| Pimecrolimus | 23 | $6,891 |
| Metronidazole | 47 | $4,513 |
| Ketoconazole | 175 | $3,417 |
| Doxycycline Hyclate | 66 | $2,136 |
| Tretinoin | 13 | $1,871 |
| Betamethasone Valerate | 11 | $1,593 |
| Tacrolimus | 14 | $1,348 |
| Minoxidil | 74 | $1,159 |
| Fluocinonide | 27 | $1,009 |
| Clindamycin Phosphate | 22 | $857 |
| Triamcinolone Acetonide | 122 | $852 |
| Mometasone Furoate | 51 | $815 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Meridian
- Ryan HarrisMeridian$58K
- Mark SchwendimanMeridian$9K
- Kelsey FerrellMeridian$6K
- Randall BurrMeridian$5K
- Benjamin PerryMeridian$4K
- Richard ThomasMeridian$4K
- Whitney VinsonMeridian$3K
- Alan PittMeridian$2K
- Emily BoozalisMeridian$2K
- Ryan WellsMeridian$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.